A new study suggests that the use of biologics in patients with inflammatory skin diseases is safe during the Covid-19 pandemic.

A study in the British Journal of Dermatology appears to show that alcohol misuse can be associated with poor response to systemic...

New research has suggested that the levels of interferon kappa, a skin protein, may be linked to the severity of psoriasis.

A recent evaluation of studies on the risk of Covid-19 in patients with psoriasis and psoriatic arthritis has suggested a high risk of bias.

Study results indicate that maintenance doses of bimekizumab (320 mg) every four or eight weeks can maintain high levels of skin...

A new study adds fresh evidence supporting previous findings regarding the independent mortality risk associated with psoriasis. The...

A retrospective study from the Taiwan National Health Insurance Research Database of 92,374 patients with psoriasis indicates that those...

New research from Italy indicates that patients with psoriasis who have been treated with biologic therapies may have a lesser risk of...